The classification of the breast tumour into the different cell-of-origin subtypes was validated using IHC for ER, PR, ErbB2, EGFR and CK5/6 using a TMA containing core biopsies of each breast tumour in our gene-expression data set. This evidence concerns the gene ERBB2 and breast neoplasm.